3 Rock-Solid Pharma Stocks to Buy Now and Hold Forever
Almost every portfolio needs a couple of anchor stocks that tend to grow consistently over time regardless of the mood of the market or the state of the economy. Thanks to the must-buy nature of lifesaving medicines and the regular launch of new and improved drugs, pharma stocks are a good place to look for the anchors that might be right for you.
In that vein, there are three rock-solid pharma stocks in particular that are strong enough to buy today and enduring enough to hold for years, accruing growth all along the way. Let's take a look at each to appreciate why they could be great additions to your portfolio.
Abbott Laboratories (NYSE: ABT) offers the diversification and stability that most investors want from pharma stocks but often struggle to find. In the second quarter, its portfolio of pharmaceuticals brought in nearly $1.3 billion, up by 8.1% year over year.
Source Fool.com
Abbott Laboratories Aktie
Abbott Laboratories als klarer Gewinner: Nur Buy-Einschätzungen, keine Sell-Einschätzungen.
Mit einem Kursziel von 127 € für Abbott Laboratories ist ein leichter Anstieg gegenüber dem aktuellen Kurs von 113.76 € zu erwarten.
